Read more at MarketWatch.
Regeneron accused of ‘fraudulent’ drug-pricing reporting for eye drug Eylea
Date: |
Sort by
Filter
Date
Items per page
-
Sanders launches investigation into 'unacceptable' diabetes, weight loss drug prices
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, ...The Hill - Politics -
Sanders locks onto next drug pricing target: Ozempic
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Sanders locks onto next drug pricing target: Ozempic After successfully getting manufacturers to lower the prices of insulin and inhalers, Sen. Bernie Sanders ...The Hill - Politics -
California moves to cut medicine prices with novel deal on opioid overdose drugs
US state to buy naloxone nasal spray from generics maker and distribute medication under its own brandFinancial Times - World - California -
The New Drug Threat
An investigation into the supply of illegal synthetic opioid drugs called nitazenes.BBC News - Top stories -
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.CNBC - Business -
Man jailed for trying to smuggle drugs into country
Yahoo News - World -
Biden grants clemency to 16 nonviolent drug offenders
"America is a nation founded on the promise of second chances," President Biden said in a statement.CBS News - Politics - Joe Biden -
Biden grants clemency to 16 nonviolent drug offenders
"America is a nation founded on the promise of second chances," President Biden said in a statement.CBS News - Politics - Joe Biden -
How one state is trying to make weight loss drugs cheaper
Weight loss drugs aren't covered by insurance for North Carolina's state employees. The state is negotiating with drugmakers Eli Lilly and Novo Nordisk to try to lower the costs.NBC News - Top stories -
Insurers scale back reimbursements for drugs used for weight loss
A growing number of insurance carriers say they won't cover the cost of weight loss medications because it is too high. The change is forcing some patients to take desperate measures. NBC News' Erin McLaughlin reports.NBC News - Top stories
More from MarketWatch
-
Peacock raising prices by $2 a month ahead of Summer Olympics
Peacock is raising prices again, a year after its last price hike and just in time for the Summer Olympics.MarketWatch - Business -
Paramount CEO Bob Bakish is stepping down, to be replaced by 3 executives
Media and entertainment giant Paramount Global on Monday said that Chief Executive Bob Bakish was stepping down and would be replaced by a three-person office intended to help “materially streamline operations.”MarketWatch - Business -
AMC’s stock registers biggest decline in a month after preliminary first-quarter results
Shares of AMC Entertainment Holdings Inc. ended Monday’s session down 11.1% as the stock registered its biggest decline since April 1, when it fell 15.6%.MarketWatch - Business -
AT&T’s stock is misunderstood. Here are five reasons Barclays says it can soar.
AT&T’s decisions in recent years look better than those made by rivals, according to Barclays.MarketWatch - Business -
Coursera, Chegg stocks fall after weaker guidance for both edtech companies
Shares of Coursera Inc. and Chegg Inc. fell in the after-hours session Monday after both education-tech companies guided for weaker current quarters, and Chegg also announced a CEO change.MarketWatch - Business